Geode Capital Management, LLC Galera Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$0.09 - $0.27 $11,441 - $34,323	127,123 Added 40.59%	440,349 $61,000
Q3 2023 Nov 13, 2023	SELL	$0.17 - $3.0 $734 - $12,969	-4,323 Reduced 1.36%	313,226 $56,000
Q2 2023 Aug 11, 2023	BUY	$2.5 - $3.42 $303,272 - $414,876	121,309 Added 61.82%	317,549 $990,000
Q1 2023 May 15, 2023	BUY	$1.48 - $2.68 $31,547 - $57,126	21,316 Added 12.19%	196,240 $502,000
Q4 2022 Feb 13, 2023	BUY	$1.34 - $1.78 $12,425 - $16,505	9,273 Added 5.6%	174,924 $260,000
Q3 2022 Nov 14, 2022	BUY	$1.15 - $2.1 $99,230 - $181,202	86,287 Added 108.72%	165,651 $288,000
Q1 2022 May 13, 2022	BUY	$2.01 - $4.19 $8,484 - $17,685	4,221 Added 5.62%	79,364 $188,000
Q4 2021 Feb 11, 2022	SELL	$1.27 - $8.28 $262 - $1,713	-207 Reduced 0.27%	75,143 $344,000
Q3 2021 Nov 12, 2021	BUY	$7.04 - $10.49 $28,821 - $42,946	4,094 Added 5.75%	75,350 $610,000
Q2 2021 Aug 13, 2021	SELL	$6.08 - $10.44 $273,660 - $469,904	-45,010 Reduced 38.71%	71,256 $700,000
Q1 2021 May 12, 2021	BUY	$8.35 - $12.39 $21,359 - $31,693	2,558 Added 2.25%	116,266 $1.03 Million
Q4 2020 Feb 12, 2021	BUY	$8.02 - $12.81 $97,122 - $155,129	12,110 Added 11.92%	113,708 $1.16 Million
Q3 2020 Nov 13, 2020	BUY	$6.96 - $9.12 $51,594 - $67,606	7,413 Added 7.87%	101,598 $918,000
Q2 2020 Aug 13, 2020	BUY	$7.14 - $14.41 $321,071 - $647,988	44,968 Added 91.37%	94,185 $672,000
Q1 2020 May 14, 2020	BUY	$5.89 - $17.67 $69,755 - $209,265	11,843 Added 31.69%	49,217 $467,000
Q4 2019 Feb 13, 2020	BUY	$9.13 - $13.9 $341,224 - $519,498	37,374 New	37,374 $491,000

909K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.07M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.